Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma board meetings
137 filed, newest first. Page 2 of 3.
Aug 2021
6 Aug · Board meeting
Jul 2021
15 Jul · Board meeting
12 Jul · Board meeting
May 2021
22 May · Board meeting
15 May · Board meeting
Feb 2021
9 Feb · Board meeting
2 Feb · Board meeting
Nov 2020
11 Nov · Board meeting
Sep 2020
7 Sep · Board meeting
Aug 2020
31 Aug · Board meeting
Jun 2020
29 Jun · Board meeting
26 Jun · Board meeting
Feb 2020
17 Feb · Board meeting
11 Feb · Board meeting
Nov 2019
14 Nov · Board meeting
Aug 2019
12 Aug · Board meeting
6 Aug · Board meeting
Jun 2019
3 Jun · Board meeting
May 2019
24 May · Board meeting
Feb 2019
13 Feb · Board meeting
7 Feb · Board meeting
Jan 2019
29 Jan · Board meeting
22 Jan · Board meeting
Nov 2018
30 Nov · Board meeting
30 Nov · Board meeting
23 Nov · Board meeting
Aug 2018
Apr 2018
17 Apr · Board meeting
11 Apr · Board meeting
Mar 2018
16 Mar · Board meeting
5 Mar · Board meeting
Feb 2018
23 Feb · Board meeting
May 2017
26 May · Board meeting
Jan 2017
Oct 2016
Aug 2016
May 2016
18 May · Board meeting
Feb 2016
Oct 2015
Aug 2015
May 2015
Mar 2015
27 Mar · Board meeting
Feb 2015
2 Feb · Board meeting
To take on record the unaudited financial results of Orchid for the period from October 01, 2014 to December 31, 2014.
Nov 2014
Aug 2014
5 Aug · Board meeting
To take on record the unaudited financial results of the Company for the period from April 01, 2014 to June 30, 2014.
Jul 2014
14 Jul · Board meeting